Springer Nature
Browse
12882_2019_1228_MOESM2_ESM.docx (37.61 kB)

Additional file 2: of The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease

Download (37.61 kB)
journal contribution
posted on 2019-01-31, 05:00 authored by Marc Evans, Eirini Palaka, Hans Furuland, Hayley Bennett, Cecilia Linde, Lei Qin, Phil McEwan, Ameet Bakhai
Table S1. Summary of methods employed to model disease progression and events in CKD patients. Table S2. Inputs applied to modelled health states and events. (DOCX 37 kb)

Funding

AstraZeneca

History

Usage metrics

    BMC Nephrology

    Categories

    Keywords

    Chronic kidney diseasePotassium, HyperkalaemiaRenin-angiotensin-aldosterone system inhibitorEconomic modelling

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC